Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Buparlisib plus fulvestrant versus placebo plus fulvestrant for postmenopausal, hormone receptor-positive, human epidermal growth factor receptor 2-negative, advanced breast cancer: Overall survival results from BELLE-2.

Campone M, Im SA, Iwata H, Clemons M, Ito Y, Awada A, Chia S, Jagiełło-Gruszfeld A, Pistilli B, Tseng LM, Hurvitz S, Masuda N, Cortés J, De Laurentiis M, Arteaga CL, Jiang Z, Jonat W, Le Mouhaër S, Sankaran B, Bourdeau L, El-Hashimy M, Sellami D, Baselga J.

Eur J Cancer. 2018 Nov;103:147-154. doi: 10.1016/j.ejca.2018.08.002. Epub 2018 Sep 18.

PMID:
30241001
2.

Oral health knowledge, attitudes, and practices (KAP) in rural Haiti: a 40-year follow-up study.

Katz RV, Prophete SE, Lafontant C, Gebrian B, Bourdeau LC, Joseph JE, Lafontant GJ, St Jean HL, Rundberg PE.

J Public Health Dent. 2018 Jun;78(3):192-196. doi: 10.1111/jphd.12270. Epub 2018 Apr 14.

PMID:
29656419
3.

Molecular Alterations and Buparlisib Efficacy in Patients with Squamous Cell Carcinoma of the Head and Neck: Biomarker Analysis from BERIL-1.

Soulières D, Licitra L, Mesía R, Remenár É, Li SH, Karpenko A, Chol M, Wang YA, Solovieff N, Bourdeau L, Sellami D, Faivre S.

Clin Cancer Res. 2018 Jun 1;24(11):2505-2516. doi: 10.1158/1078-0432.CCR-17-2644. Epub 2018 Feb 28.

4.

Transcriptomics and Lipidomics of the Environmental Strain Rhodococcus ruber Point out Consumption Pathways and Potential Metabolic Bottlenecks for Polyethylene Degradation.

Gravouil K, Ferru-Clément R, Colas S, Helye R, Kadri L, Bourdeau L, Moumen B, Mercier A, Ferreira T.

Environ Sci Technol. 2017 May 2;51(9):5172-5181. doi: 10.1021/acs.est.7b00846. Epub 2017 Apr 12.

PMID:
28345896
5.

Safety of enfuvirtide in combination with an optimized background of antiretrovirals in treatment-experienced HIV-1-infected adults over 48 weeks.

Trottier B, Walmsley S, Reynes J, Piliero P, O'Hearn M, Nelson M, Montaner J, Lazzarin A, Lalezari J, Katlama C, Henry K, Cooper D, Clotet B, Arastéh K, Delfraissy JF, Stellbrink HJ, Lange J, Kuritzkes D, Eron JJ Jr, Cohen C, Kinchelow T, Bertasso A, Labriola-Tompkins E, Shikhman A, Atkins B, Bourdeau L, Natale C, Hughes F, Chung J, Guimaraes D, Drobnes C, Bader-Weder S, Demasi R, Smiley L, Salgo MP.

J Acquir Immune Defic Syndr. 2005 Dec 1;40(4):413-21.

PMID:
16280695
6.

Clinical evaluation of the accuracy of the Evident RCM Mark II Apex Locator.

Ricard O, Roux D, Bourdeau L, Woda A.

J Endod. 1991 Nov;17(11):567-9.

PMID:
1812206

Supplemental Content

Loading ...
Support Center